The weekly litigation news digest is live. Subscribe now

Patent Oppositions in respiratory drugs industry

Explore the competitive field of respiratory drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in respiratory drugs technology and learn how to protect your intellectual property.

Get Patent Opposition Report for respiratory drugs

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the respiratory drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the respiratory drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Nov 20, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name
Method And Compositions For Cellular ImmunotherapyFRED HUTCHINSON CANCER CENTEROct 8, 2025BOULT WADE TENNANT
Combination Therapy For Inhalation AdministrationCHEMO RESEARCHOct 1, 2025HIGHTONE MANAGEMENT
Solid Oral Formulation Of FenretinideLAURENT PHARMACEUTICALSSep 9, 2025WUESTHOFF & WUESTHOFF
Therapeutic Agent And Therapeutic Method For Pulmonary HypertensionKYOWA KIRINJul 16, 2025J A KEMP
Therapeutic Agent And Therapeutic Method For Pulmonary HypertensionKYOWA KIRINJul 15, 2025ALTMANN STOSSEL DICK PATENTANWALTE PARTG MBB
Methods For Reducing Lipoprotein(A) Levels By Administering An Inhibitor Of Proprotein Convertase Subtilisin Kexin-9 (Pcsk9)REGENERON PHARMACEUTICALSJun 23, 2025AMGEN
Use Of Substituted Aminopropionate Compounds In Treatment Of Sars-Cov-2 InfectionACADEMY OF MILITARY MEDICAL SCIENCESJun 18, 2025GILEAD SCIENCES
Mixture Of Non-Digestible Oligosaccharides For Stimulating The Immune SystemNUTRICIAApr 10, 2025NESTLE
Mixture Of Non-Digestible Oligosaccharides For Stimulating The Immune SystemNUTRICIAMar 27, 2025ARLA FOODS AMBA
Composition For Nasal Application With Improved StabilityMARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFTMar 26, 2025KRKA

To stay ahead in the competitive respiratory drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the respiratory drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleApplicantTotal Oppositions
Dec 11, 2019Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor AgonistNOVARTIS10
May 22, 2019Pharmaceutical Formulations Comprising 4-{(1R)-2- [(6-{2-[(2,6-Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2- (Hydroxymethyl)PhenolGLAXO GROUP8
Nov 1, 2023Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGY7
Jan 10, 2024Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS7
May 13, 2020Methods Of Administering Pirfenidone TherapyINTERMUNE6
Mar 29, 2017Compositions And Methods Of Treating Pulmonary HypertensionGILEAD SCIENCES6
Jun 26, 2024Pharmaceutical Formulations Comprising 4-{(1 R)-2-[(6-{2-[(2,6-Dichlorobenzyl)Oxy]Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2-(Hydroxymethyl)PhenolGLAXO GROUP6
Apr 17, 2024Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor AgonistGLAXO GROUP5
Jan 15, 2020Dry Powder Formulations Comprising VilanterolARVEN ILAC SANAYI VE TICARET4
May 20, 2020Methods Of Administering Fluvoxamine TherapyINTERMUNE4